What happens when the architect behind the Transformer turns his focus to RNA and molecular design? Jakob Uszkoreit, Co-Founder of Inceptive and co-author of Attention is All You Need, joins John Cumbers, founder and CEO of SynBioBeta, for a conversation at the intersection of AI and biology. As synthetic biology enters the age of hyperscale—powered by generative models, molecular learning, and programmable therapeutics—Jakob shares his vision for reimagining intelligence not just in machines, but in the molecules that power life. Don’t miss this rare dialogue on the future of biodesign, computation, and the growing interface between synthetic biology and deep learning.

P&G is a leading consumer products company led by consumer insights- they can tell you that today’s consumers want clean, healthy products in their homes to provide for their families' personal care needs. To meet these expectations, innovators are integrating new approaches to transform their supply chains, minimize waste streams, and drive environmentally sound solutions for a more sustainable planet. Join two senior leaders for a closer look at how synbio can positively impact consumer products and what specific challenges–both technical and societal–we need to solve to get there. Hear how corporate leaders evaluate new innovations and where they see unmet needs in the market. This session will highlight how corporates and startups can work together to achieve the functional and sustainable performance consumers demand.

Join an engaging fireside chat exploring the future landscape of bioinnovation, where visionary ideas meet real-world applications. Discover how cutting-edge technologies in synthetic biology, healthcare, and biomanufacturing are reshaping our world—from regenerative medicine and organ engineering to accessible global healthcare solutions. Learn how interdisciplinary collaboration, creativity, and bold entrepreneurial thinking are driving breakthroughs that promise not only to transform human health but also redefine what it means to innovate for impact.